Cargando…
Malignant Pleural Effusions—A Window Into Local Anti-Tumor T Cell Immunity?
The success of immunotherapy that targets inhibitory T cell receptors for the treatment of multiple cancers has seen the anti-tumor immune response re-emerge as a promising biomarker of response to therapy. Longitudinal characterization of T cells in the tumor microenvironment (TME) helps us underst...
Autores principales: | Principe, Nicola, Kidman, Joel, Lake, Richard A., Lesterhuis, Willem Joost, Nowak, Anna K., McDonnell, Alison M., Chee, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111299/ https://www.ncbi.nlm.nih.gov/pubmed/33987104 http://dx.doi.org/10.3389/fonc.2021.672747 |
Ejemplares similares
-
Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses
por: Kidman, Joel, et al.
Publicado: (2020) -
Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors
por: Chee, Jonathan, et al.
Publicado: (2018) -
Malignant pleural effusion: Updates in diagnosis, management and current challenges
por: Addala, Dinesh Narayan, et al.
Publicado: (2022) -
Tumor Infiltrating Effector Memory Antigen-Specific CD8(+) T Cells Predict Response to Immune Checkpoint Therapy
por: Principe, Nicola, et al.
Publicado: (2020) -
Current status of and progress in the treatment of malignant pleural effusion of lung cancer
por: Zhao, Yuhua, et al.
Publicado: (2023)